Study identifier:NIS-CME-CRE-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Efficiency of rosuvastatin versus the fixed combination of Ezetimibe/Simvastatin to reduce the cholesterol levels in outpatients in a realistic environment. A Retrospective Study
Dyslipidemia
-
No
-
All
268
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Dislipidemic Population People with high levels of total cholesterol, LDL, C-HDL and triglycerides | - |